美研究显示颅内出血使用阿司匹林是安全的

 
 
一项最新研究提示抗血小板药物例如阿司匹林，不会增加颅内出血(ICH)后进一步出血的危险。

这项研究涉及了127例患者小叶颅内出血患者和80例重度颅内出血的患者，这些患者1994年至2004年在麻省总院(Boston, MA, USA)接受了治疗，在颅内出血后6个月接受随访，以后每个6个月同样接受随访。这些研究结果在2006年1月24日的《神经病学》期刊上进行了报道。

在随访期间，56例患者开始使用阿司匹林，1例clopidogrel。适应症包括缺血性心脏疾病、房颤、人造瓣膜、缺血性脑卒中、暂时系性缺血性发作。39例患者出现再发性颅内缺血。分析显示：小叶颅内出血或者重度颅内出血幸存者中使用抗血小板药物，与再发出血危险增高之间并不相关。

Aspirin Use Safe After Intracerebral Hemorrhage
 
A new study suggests that antiplatelet agents such as aspirin do not increase the risk of a further recurrence following an intracerebral hemorrhage (ICH).

The study included 127 patients with lobar ICH and 80 with deep ICH who had been treated at Massachusetts General Hospital (Boston, MA, USA) between 1994 and 2004 and were interviewed at three and six months post ICH and every six months thereafter. The results were reported in the January 24, 2006, issue of Neurology.

Forty-six of the subjects began using aspirin, or in one case clopidogrel, during follow-up. Indications included ischemic heart disease, atrial fibrillation, artificial heart valve, ischemic stroke, and transient ischemic attack. There were 39 subjects with recurrent ICH. Analyses showed that antiplatelet agents were not associated with a significantly increased risk of recurrent hemorrhage among lobar ICH survivors or deep ICH survivors.